<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.967" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">451</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285â€“496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 638.310 L93.620 638.310 "/>
  <g begin="text">
   <text y="77.112" x="62.362,68.86,73.36,75.862,79.858,83.854,87.355,90.856,93.358,95.86,100.36,103.861,107.857,110.107,116.605,121.105,124.606,129.106,131.608,134.11,138.61,141.112,143.362,145.612,151.615,155.611,160.111,163.612,168.112,171.613,175.114,179.614,184.114,186.616,191.116,193.618,198.118,202.618,206.614,208.864,215.362,219.358,223.858,228.358,231.859,234.361,240.859,244.855,249.355,251.857,254.107,256.357,263.854,268.354,271.855,275.851,278.353,282.853,285.103" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.5,0.39,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.39,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.25,0.83,0.5,0.39,0.44,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Universitary Hospital, Neurorradiology Department, Murcia, </text>
   <text y="88.11" x="62.362,66.862,71.362,75.862,78.364" svgx:width="0.5,0.5,0.5,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Spain</text>
   <text y="115.11" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="115.11" x="115.624,122.122,126.622,129.124,131.626,134.128,137.044,141.544,146.044,150.211,154.711,156.961,159.877,164.377,168.373,170.875,174.871,177.373,179.875,183.871,188.371,195.373,199.369,203.869,206.785,209.782,216.28,221.779,227.278,230.275,233.191,239.689,243.685,247.186,250.102,252.604,257.104,261.1,264.016,266.518,269.515,273.511,277.507,280.009,287.011,291.007,295.507,298.009" svgx:width="0.72,0.5,0.28,0.28,0.28,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.33,0.72,0.61,0.61,0.33,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.44,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Until 2011, natalizumab (NTZ) was the treatment </text>
   <text y="126.108" x="62.362,66.862,69.859,72.109,73.243,77.239,81.739,86.239,88.741,92.737,96.733,98.983,100.117,102.619,107.119,109.369,110.503,115.003,118.999,121.501,124.003,127.999,132.499,135.001,138.502,140.752,141.886,148.384,150.886,153.388,157.888,160.138,161.272,164.269,168.265,170.767,174.763,179.263,182.764,185.266,189.766,194.266,197.263,200.26,204.256,211.258,213.76,216.262,218.764,221.266,225.766,230.266,232.516,233.65,240.652,245.152,247.654,250.156,252.658,257.158,259.66,263.656,265.906,267.04,270.541,274.537,277.039,281.035,284.032,288.532,292.033,294.535,298.036" svgx:width="0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.28,0.44,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of choice in patients with relapsing-remitting multiple sclerosis </text>
   <text y="137.106" x="62.362,65.359,71.362,77.365,85.366,90.37,93.367,95.887,102.385,106.885,111.385,113.905,118.405,122.401,126.901,129.421,133.921,138.421,140.923,143.443,146.44,150.436,153.937,158.437,162.937,167.437,171.937,175.933,180.433,182.953,186.949,189.946,192.448,196.444,199.441,201.961,205.957,208.477,212.473,216.973,221.473,224.47,227.971,231.967,234.487,238.987,241.984,244.504,247.006,254.008,261.01,265.51,270.01,274.51,281.512,286.012,290.512,295.012" svgx:width="0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.72,0.5,0.5,0.25,0.5,0.44,0.5,0.25,0.5,0.5,0.28,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.44,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.78,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(RRMS) who had not responded after a course of immunomodu-</text>
   <text y="148.104" x="62.362,64.864,68.86,71.362,75.862,78.859,83.359,85.609,86.356,88.858,93.358,97.354,100.351,104.347,108.847,113.347,115.597,116.344,119.341,122.338,130.339,135.838,138.835,141.085,143.335,144.082,148.078,152.578,157.078,159.328,160.075,162.577,167.077,169.327,170.074,172.576,177.076,181.576,185.077,189.073,191.323,192.07,198.568,201.07,203.572,208.072,210.322,211.069,215.065,219.565,224.065,227.062,231.058,234.559,238.06,240.562,245.062,249.058,251.308,252.055,256.555,261.055,264.556,268.552,271.054,273.304,274.051,278.551,281.548,283.798,284.545,289.045,291.547,295.048" svgx:width="0.28,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.33,0.33,0.89,0.61,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.5,0.39,0.44,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.39,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">latory therapy (IMT), and in those with aggressive onset of dis-</text>
   <text y="159.102" x="62.362,66.358,70.354,73.855,77.851,80.101,82.351,86.437,89.434,93.934,96.184,100.27,103.771,108.271,115.273,119.269,121.519,125.605,130.105,134.101,136.603,139.105,143.101,147.601,150.103,153.604,155.854,158.104,162.19,164.692,169.192,173.188,175.438,179.524,182.521,185.023,188.524,193.024,195.274,199.36,203.86,206.857,209.107,213.193,217.693,220.69,225.19,229.69,232.687,236.683,240.184,243.685,246.187,250.687,254.683,256.933,261.019,268.021,272.521,275.023,277.525,280.027,283.024,287.524,291.52,295.516,298.018" svgx:width="0.44,0.44,0.39,0.44,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.39,0.5,0.78,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ease. In some patients, the risk of progressive multifocal </text>
   <text y="170.1" x="62.362,64.864,68.86,73.36,77.86,82.36,86.356,90.856,94.852,98.848,103.348,107.848,111.844,114.346,118.846,123.346,127.342,129.844,134.344,138.844,141.094,142.039,145.036,150.04,158.041,163.54,166.537,168.787,169.732,173.728,177.724,182.224,185.725,189.721,193.222,195.472,196.417,202.915,208.414,213.913,216.163,217.108,223.606,226.108,228.61,233.11,237.61,240.607,244.603,251.101,255.097,257.599,259.849,260.794,265.294,269.29,272.791,277.291,279.793,282.295,286.291,288.541,289.486,291.988,294.49,297.991" svgx:width="0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.33,0.56,0.89,0.61,0.33,0.25,0.55,0.44,0.44,0.5,0.39,0.44,0.39,0.25,0.55,0.72,0.61,0.61,0.25,0.55,0.72,0.28,0.28,0.5,0.5,0.33,0.44,0.72,0.44,0.28,0.25,0.55,0.5,0.44,0.39,0.5,0.28,0.28,0.44,0.25,0.55,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">leukoencephalopathy (PML) causes NTZ withdrawal despite its </text>
   <text y="181.098" x="62.362,66.358,69.193,72.19,74.692,78.688,82.684,86.68,90.595,92.845,95.122,100.126,102.628,107.128,111.628,116.128,118.63,121.132,128.134,132.634,137.134,139.411,145.909,149.905,153.406,155.683,159.679,164.179,168.679,171.676,176.176,180.676,184.672,189.172,191.449,193.951,198.451,200.728,205.228,209.728,213.895,218.395,220.672,227.17,229.672,232.174,236.674,238.951,241.453,245.953,249.949,252.226,255.727,259.723,266.725,270.721,272.998,275.5,280.0,284.5,287.002,290.998,294.994" svgx:width="0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.5,0.25,0.25,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.78,0.44,0.25,0.28,0.5,0.5,0.28,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">efficacy. Fingolimod was approved in 2011 with the same indica-</text>
   <text y="192.096" x="62.362,64.864,67.366,71.866,76.366,79.867,82.117,86.113,89.614,91.864,98.362,103.861,109.36" svgx:width="0.28,0.28,0.5,0.5,0.39,0.25,0.44,0.39,0.25,0.72,0.61,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tions as NTZ.</text>
   <text y="203.094" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="203.094" x="107.947,115.723,119.719,121.816,126.316,129.313,133.309,136.81,140.806,145.306,147.808,149.905,154.405,158.401,161.398,165.394,167.491,171.487,173.584,177.085,181.081,184.078,186.58,190.576,194.077,196.174,200.674,203.671,205.768,210.268,214.264,216.766,219.268,223.264,227.764,230.266,233.767,235.864,238.366,241.363,245.359,249.355,251.857,255.853,260.353,262.45,268.948,271.45,273.952,278.452,280.549,287.047,292.546,298.045" svgx:width="0.94,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.5,0.44,0.33,0.44,0.25,0.44,0.25,0.39,0.44,0.33,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.61,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We present here a series of patients treated with NTZ </text>
   <text y="214.092" x="62.362,67.438,71.938,74.152,78.652,82.648,86.644,89.641,93.142,95.356,99.352,103.852,108.352,110.566,117.064,119.566,122.068,126.568,128.782,133.282,137.782,141.283,143.785,146.287,148.789,153.289,157.285,159.499,163.495,167.995,170.497,172.999,177.499,181.999,186.499,189.001,192.997,196.498,198.712,201.214,205.714,207.928,211.429,217.432,219.646,224.146,226.648,229.645,234.145,237.646,239.86,242.857,246.358,252.361,258.859,261.856,264.106,266.32,268.822,273.322,275.536,282.034,286.534,291.034,298.036" svgx:width="0.56,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.44,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.33,0.39,0.67,0.72,0.33,0.25,0.25,0.28,0.5,0.25,0.72,0.5,0.5,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">&gt;2 years and with positive antibodies to JC virus (JCV), in whom </text>
   <text y="225.09" x="62.362,68.86,74.359,79.858,82.279,88.777,92.773,96.274,98.695,103.195,105.697,109.198,113.194,117.694,122.194,124.696,127.198,131.698,136.198,140.194,144.694,147.115,151.615,156.115,160.111,162.532,165.034,169.534,171.955,175.456,179.452,182.449,186.445,188.947,193.447,195.868,198.865,202.861,206.857,210.358,214.858,219.358,222.859,225.28,229.276,233.776,238.276,240.697,243.694,247.69,252.19,254.692,258.688,262.684,266.68,271.18,273.601,278.101,282.601,285.022,288.019,290.521,295.021" svgx:width="0.72,0.61,0.61,0.25,0.72,0.44,0.39,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.33,0.44,0.44,0.39,0.5,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.5,0.28,0.44,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.33,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NTZ was discontinued due to safety reasons and replaced by fin-</text>
   <text y="236.088" x="62.362,66.862,71.362,73.864,76.366,83.368,87.868,92.368,94.618,96.868,99.82,107.596,111.592,113.842,116.956,120.952,125.452,129.448,131.95,136.45,139.951,143.947,148.447,150.697,153.811,156.313,160.813,164.809,167.059,170.173,174.169,176.671,179.173,183.673,186.175,190.171,194.167,196.669,198.919,201.169,204.283,207.28,211.276,215.776,218.278,222.778,225.28,229.78,234.28,236.782,240.778,244.774,247.276,249.526,252.64,256.636,260.632,263.134,265.636,270.136,272.638,275.14,279.64,281.89,285.004,289.0,293.5,298.0" svgx:width="0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.25,0.55,0.94,0.44,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.25,0.55,0.33,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">golimod. We analysed the clinical, radiological activity and </text>
   <text y="247.086" x="62.362,66.358,70.858,75.358,79.354,82.351,85.852,89.848,92.098,95.095,99.091,103.087,107.083,109.585,112.087,116.587,121.087,124.588,126.838,131.338,135.838,138.835,141.337,145.837,150.337,152.587,155.089,159.589,163.585,165.835,170.335,172.585,177.085,181.081,185.077,188.074,191.575,193.825,200.323,202.825,205.327,209.827,212.077,215.074,217.576,222.076,226.576,231.076,233.578,236.08,243.082,247.582,252.082" svgx:width="0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">adverse reactions during the 2 years with fingolimod.</text>
   <text y="258.084" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="258.084" x="100.945,108.721,112.717,114.805,118.306,122.302,124.804,128.8,132.796,135.298,139.294,143.794,145.882,149.878,152.38,154.882,156.97,160.471,166.474,172.144,175.141,179.641,184.141,187.642,190.144,192.646,195.148,199.648,203.644,205.732,210.232,214.228,216.73,219.232,223.228,227.728,230.23,233.731,235.819,238.321,241.318,245.314,249.31,251.812,255.808,260.308,262.396,268.894,271.396,273.898,278.398,280.486,286.984,292.483,297.982" svgx:width="0.94,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.44,0.28,0.28,0.25,0.39,0.67,0.72,0.33,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.61,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We selected all JCV-positive patients treated with NTZ </text>
   <text y="269.082" x="62.362,67.438,71.938,74.764,79.264,83.26,87.256,90.253,93.754,96.58,103.078,107.578,112.078,114.904,119.404,121.906,125.407,129.403,133.903,138.403,140.905,143.407,147.907,152.407,156.403,160.903,163.729,166.231,169.228,173.224,177.22,179.722,186.724,190.72,195.22,197.722,200.548,205.048,209.044,211.546,218.044,222.04,226.036,230.536,233.362,236.863,240.859,245.359,249.859,253.855,256.852,261.352,264.178,268.678,273.178,277.678,282.178,285.004,289.0,293.5,298.0" svgx:width="0.56,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.72,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.39,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">&gt;2 years who discontinued treatment between January 2012 and </text>
   <text y="280.08" x="62.362,65.863,69.859,74.359,78.859,82.855,85.852,90.352,92.602,93.7,98.2,102.7,107.2,111.7,113.95,116.2,117.298,122.302,124.804,129.304,133.804,138.304,140.806,143.308,150.31,154.81,159.31,161.56,162.658,167.158,169.408,173.908,176.158,177.256,184.258,188.758,191.008,192.106,196.606,200.602,203.104,205.606,210.106,212.356,213.454,219.952,223.948,227.449,229.699,230.797,233.299,237.799,240.301,242.803,245.305,249.301,251.803,255.799,260.299,262.549,263.647,268.147,270.397,271.495,278.497,282.997,287.497,289.999,294.499,298.0" svgx:width="0.39,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.5,0.25,0.5,0.25,0.55,0.78,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">January 2014. Fingolimod 0.5 mg daily was initiated 3 months </text>
   <text y="291.078" x="62.362,66.358,69.355,71.857,75.853,78.85,81.172,87.67,93.169,98.668,100.99,107.488,109.99,112.492,116.992,121.492,124.489,128.485,134.983,138.979,141.481,143.731,146.053,151.552,154.054,158.05,162.046,164.548,167.545,172.045,176.041,180.037,183.034,187.534,190.036,194.536,199.036,202.033,206.029,213.031,215.353,218.35,223.849,229.852,236.35,239.347,241.669,248.671,253.171,257.671,260.173,262.675,267.175,270.172,272.674,277.174,281.674,283.996,290.494,294.49,297.991" svgx:width="0.44,0.33,0.28,0.44,0.33,0.25,0.72,0.61,0.61,0.25,0.72,0.28,0.28,0.5,0.5,0.33,0.44,0.72,0.44,0.28,0.25,0.25,0.61,0.28,0.44,0.44,0.28,0.33,0.5,0.44,0.44,0.33,0.5,0.28,0.5,0.5,0.33,0.44,0.78,0.25,0.33,0.61,0.67,0.72,0.33,0.25,0.78,0.5,0.5,0.28,0.28,0.5,0.33,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">after NTZ withdrawal. Electrocardiogram (ECG) monitoring was </text>
   <text y="302.076" x="62.362,66.862,70.858,73.855,76.852,81.352,84.349,91.351,95.347,99.847,102.214,106.714,111.214,114.211,116.713,121.213,125.713,128.08,130.582,135.082,139.078,141.445,144.442,146.944,149.941,153.442,155.944,158.311,162.811,167.311,170.812,174.808,177.058,179.425,183.421,187.921,192.421,194.788,201.79,205.786,210.286,214.786,218.782,221.284,223.786,227.782,230.149,233.146,237.142,240.643,245.143,249.643,253.639,258.139,262.135,266.131,268.498,271.0,278.002,281.998,286.498,289.0,293.5,298.0" svgx:width="0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.33,0.39,0.28,0.25,0.5,0.5,0.39,0.44,0.25,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.5,0.5,0.44,0.28,0.28,0.44,0.25,0.33,0.44,0.39,0.5,0.5,0.44,0.5,0.44,0.44,0.25,0.28,0.78,0.44,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">performed during the first dose, and magnetic resonance imaging </text>
   <text y="313.074" x="62.362,65.359,73.36,79.363,82.36,85.357,87.607,89.128,93.628,96.625,98.875,100.396,102.898,107.398,111.394,113.644,115.165,119.665,122.662,126.658,129.16,133.66,135.91,137.431,143.929,147.925,151.426,153.676,155.197,159.697,163.693,166.69,169.687,174.187,177.184,184.186,188.182,192.682,194.932,196.453,200.449,202.951,205.201,206.722,211.222,215.218,218.719,222.715,225.217,227.719,232.219,236.215,238.465,239.986,242.983,247.483,249.733,251.254,258.256,262.756,267.256,269.758,274.258,277.759,280.009,281.53,285.526,288.523,291.025,295.021,298.018" svgx:width="0.33,0.89,0.67,0.33,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.44,0.28,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(MRI) of the brain was performed at baseline (3 months after </text>
   <text y="324.072" x="62.362,68.86,74.359,79.858,82.855,85.105,85.87,89.866,94.366,98.866,101.116,101.881,105.877,108.379,110.629,111.394,115.894,118.144,120.394,121.159,125.659,127.909,130.159,130.924,135.424,139.924,142.174,142.939,146.935,151.435,155.935,158.185,158.95,163.45,167.95,170.2,170.965,177.967,182.467,186.967,189.469,193.969,197.47,199.72,200.485,204.481,207.478,209.98,213.976,216.973,219.223,219.988,222.985,225.487,229.987,234.487,238.987,241.489,243.991,250.993,255.493,259.993,262.243,263.008,265.51,270.01,272.512,275.014,277.516,281.512,284.014,286.516,291.016,295.516,298.018" svgx:width="0.72,0.61,0.61,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.5,0.25,0.25,0.55,0.5,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NTZ) and at 3, 6, 12 and 24 months after fingolimod initiation; </text>
   <text y="335.07" x="62.362,64.864,68.86,73.36,77.86,80.857,84.853,87.355,91.855,94.852,99.352,101.458,105.958,109.954,112.456,116.956,120.952,124.453,126.559,133.057,137.053,140.05,144.046,146.152,150.652,154.648,157.15,161.146,164.143,171.145,173.647,178.147,182.143,186.643,188.749,192.745,195.247,197.353,201.853,205.849,209.35,213.346,215.848,218.35,222.85,226.846,229.096,231.202,235.702,237.808,244.81,249.31,253.81,256.312,260.812,262.918,266.914,271.414,275.914,278.02,282.016,286.516,290.512,293.509,298.009" svgx:width="0.28,0.44,0.5,0.5,0.33,0.44,0.28,0.5,0.33,0.5,0.25,0.5,0.44,0.28,0.5,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.5,0.25,0.44,0.28,0.25,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.44,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">laboratory values were determined at baseline, 1 month and every </text>
   <text y="346.068" x="62.362,66.862,69.112,76.114,80.614,85.114,87.616,92.116,95.617" svgx:width="0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">3 months.</text>
   <text y="357.066" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="357.066" x="97.237,102.241,105.238,109.738,116.74,118.99,120.619,124.12,128.116,132.616,137.116,141.112,144.109,148.609,150.859,152.488,156.988,161.488,165.988,170.488,172.738,174.367,176.869,181.369,183.619,185.248,188.749,192.745,197.245,201.745,205.741,208.738,213.238,215.488,217.117,221.617,226.117,230.617,235.117,237.367,239.617,241.246,245.746,250.246,252.496,254.125,258.625,262.621,265.123,267.625,271.621,276.121,278.623,282.124,284.374,286.003,289.0,293.5,298.0" svgx:width="0.56,0.33,0.5,0.78,0.25,0.55,0.39,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">From January 2012 to January 2014, 20 patients (12 </text>
   <text y="368.064" x="62.362,68.86,73.36,80.362,84.358,88.858,91.855,94.159,100.657,103.159,105.661,110.161,112.465,116.461,118.765,125.767,129.763,133.759,138.259,140.563,144.559,149.059,153.055,155.359,159.859,162.856,165.16,169.66,174.16,176.41,180.91,183.214,187.714,191.71,195.706,198.703,202.204,204.508,208.504,213.004,217.504,219.808,223.804,226.108,233.11,237.106,241.102,245.602,247.906,255.907,260.911,263.215,267.715,270.217,273.718,276.22,280.72,283.717,288.217,290.521,295.021,298.018" svgx:width="0.72,0.5,0.78,0.44,0.5,0.33,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.89,0.56,0.25,0.5,0.28,0.39,0.28,0.5,0.33,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">women) with a mean age of 39.9 years and a mean MS history of </text>
   <text y="379.062" x="62.362,66.862,69.112,73.612,76.087,80.587,84.583,88.579,91.576,95.077,97.552,102.052,104.554,108.055,112.051,116.551,121.051,123.553,126.055,130.555,135.055,139.051,143.551,146.026,152.524,158.023,163.522,165.997,169.993,172.99,175.492,179.488,182.485,184.96,188.956,191.431,198.433,202.429,206.425,210.925,213.4,217.9,220.897,223.372,227.872,232.372,234.847,239.347,243.847,247.348,251.344,254.845,257.095,259.57,264.07,268.57,272.566,275.041,277.543,282.043,284.518,287.515,290.017,293.518,298.018" svgx:width="0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.72,0.61,0.61,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.5,0.5,0.39,0.44,0.39,0.25,0.25,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.33,0.28,0.39,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">8.9 years discontinued NTZ after a mean of 26 doses, due to risk </text>
   <text y="390.06" x="62.362,66.862,69.859,71.92,76.924,84.925,90.424,92.674,94.24,100.738,103.24,105.742,107.803,112.303,116.299,118.801,121.303,125.299,129.799,132.301,135.802,137.863,144.361,148.357,151.354,155.35,157.411,160.912,164.908,167.905,172.405,176.905,181.405,184.906,187.408,189.91,192.412,196.912,200.908,202.969,205.966,210.466,213.463,215.524,219.025,225.028,230.86,233.362,235.423,238.42,242.92,247.42,250.417,252.478,256.978,260.974,265.474,267.535,270.532,274.528,278.524,282.52,285.022,289.522,293.518,298.018" svgx:width="0.5,0.33,0.25,0.56,0.89,0.61,0.25,0.25,0.72,0.28,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.39,0.67,0.72,0.28,0.25,0.33,0.5,0.5,0.33,0.25,0.5,0.44,0.5,0.25,0.33,0.44,0.44,0.44,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of PML. All patients were seropositive for JCV; four had received </text>
   <text y="401.058" x="62.362,66.862,69.859,72.361,76.861,79.858,82.108,83.971,86.473,93.475,100.477,104.977,109.477,113.977,117.478,121.978,126.478,130.978,133.975,137.971,141.472,144.973,148.969,153.469,155.971,158.221,160.084,164.584,167.581,172.081,176.581,180.082,182.332,184.582,185.95,192.448,194.95,197.2,199.063,205.561,211.06,216.559,218.809,220.672,225.172,227.674,231.175,235.171,239.671,244.171,246.673,249.175,253.675,258.175,262.171,264.673,267.175,271.675,276.175,278.425,280.675,282.538,285.04,289.54,293.536,298.036" svgx:width="0.5,0.33,0.28,0.5,0.33,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.39,0.25,0.25,0.55,0.72,0.28,0.25,0.55,0.72,0.61,0.61,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">prior immunosuppressant drugs. At NTZ discontinuation, they </text>
   <text y="412.056" x="62.362,68.86,72.856,75.853,79.849,82.0,85.996,88.498,91.0,95.5,98.002,101.998,105.994,108.496,110.998,115.498,117.649,121.645,126.145,130.645,132.796,135.793,139.789,144.289,146.791,151.291,153.793,158.293,162.793,165.295,169.291,173.287,175.789,178.291,182.791,184.942,188.443,190.945,194.941,199.441,201.943,205.939,208.09,211.087,218.089,222.085,226.081,230.581,232.732,238.231,244.729,249.733,254.737,256.888,261.388,263.638,268.138,270.388,272.539,275.536,279.532,282.034,286.03,290.53,294.031,298.027" svgx:width="0.72,0.44,0.33,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.39,0.28,0.44,0.5,0.28,0.44,0.25,0.33,0.78,0.44,0.44,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.5,0.25,0.5,0.25,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were clinically and radiologically stable (mean EDSS 3.5, relapse </text>
   <text y="423.054" x="62.362,65.359,69.355,71.857,75.853,78.103,82.603,84.853,89.353,91.603,93.853,97.849,102.349,106.849,111.349,115.345,117.847,120.349,124.345,128.341,132.841,135.082,138.079,142.075,144.577,148.573,153.073,156.574,160.57,162.82,165.817,169.813,172.315,176.311,178.552,181.549,188.047,194.05,200.053,203.05,205.3,209.8,212.05,216.55,221.05,224.047,226.297,228.052,234.55,237.547,240.049,244.045,247.042,249.292,251.794,256.294,260.29,262.54,265.537,268.039,271.036,274.537,277.039,279.289,283.789,288.289,291.79,295.786,298.036" svgx:width="0.33,0.44,0.28,0.44,0.25,0.5,0.25,0.5,0.25,0.25,0.44,0.5,0.5,0.5,0.44,0.28,0.28,0.44,0.44,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.33,0.44,0.28,0.44,0.25,0.33,0.72,0.67,0.67,0.33,0.25,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.72,0.33,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.33,0.39,0.28,0.25,0.5,0.5,0.39,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">rate 0.5, annualized relapse rate (ARR) 0.27). After the first dose, </text>
   <text y="434.052" x="62.362,67.861,73.864,80.362,82.612,83.377,87.373,91.873,96.373,100.873,103.87,110.872,114.868,117.37,119.872,122.374,124.876,128.872,132.373,134.623,135.388,141.886,145.882,148.879,152.875,155.125,155.89,158.887,163.387,167.887,172.387,176.887,179.137,179.902,183.898,186.4,188.65,189.415,193.915,198.415,202.915,205.165,205.93,208.432,212.932,215.182,215.947,220.447,224.947,227.197,231.697,239.194,241.444,242.209,246.709,249.706,251.956,252.721,257.221,261.217,263.719,266.221,270.217,274.717,277.219,280.72,282.97,285.22,285.985,290.485,297.982" svgx:width="0.61,0.67,0.72,0.25,0.55,0.44,0.5,0.5,0.5,0.33,0.78,0.44,0.28,0.28,0.28,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.25,0.5,0.83,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.5,0.83,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ECG abnormalities were found at 24h in 21.1% of patients, 5% </text>
   <text y="445.05" x="62.362,65.863,70.363,77.365,81.865,84.367,88.867,95.869,99.865,102.367,104.869,108.865,111.115,113.383,119.881,122.383,124.885,127.648,132.148,135.145,137.908,140.41,144.91,148.906,155.908,158.671,161.668,165.664,169.165,173.665,176.167,180.667,184.663,189.163,191.926,194.428,198.424,200.926,204.922,207.919,210.682,215.182,219.682,221.932,224.695,229.195,233.695,241.192,243.955,248.455,251.452,254.215,258.715,262.711,265.213,267.715,271.711,276.211,278.713,282.214,284.977,289.477,293.473,297.973" svgx:width="0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.44,0.28,0.28,0.44,0.25,0.25,0.72,0.28,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.78,0.25,0.33,0.44,0.39,0.5,0.28,0.5,0.44,0.5,0.25,0.28,0.44,0.28,0.44,0.33,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.83,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">symptomatic. All of them resolved later on. 25% of patients had </text>
   <text y="456.048" x="62.362,66.358,69.859,74.359,81.361,85.861,88.363,92.863,99.865,103.861,106.363,108.865,112.861,115.111,117.046,121.546,126.046,130.546,134.542,137.539,140.041,143.038,147.034,151.534,155.035,159.031,166.033,168.535,173.035,177.031,180.532,184.528,191.53,194.032,198.028,200.278,202.528,204.463,208.459,212.959,217.459,219.709,221.644,226.144,230.644,238.141,240.391,242.326,246.826,250.822,253.819,257.32,259.822,263.323,265.825,269.821,274.321,276.823,279.073,281.008,283.51,288.01,295.012" svgx:width="0.44,0.39,0.5,0.78,0.5,0.28,0.5,0.78,0.44,0.28,0.28,0.44,0.25,0.55,0.5,0.5,0.5,0.44,0.33,0.28,0.33,0.44,0.5,0.39,0.44,0.78,0.28,0.5,0.44,0.39,0.44,0.78,0.28,0.44,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.83,0.25,0.55,0.5,0.44,0.33,0.39,0.28,0.39,0.28,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">asymptomatic hypertransaminasemia, and 83% persistent lym-</text>
   <text y="467.046" x="62.362,66.862,71.362,75.862,80.362,84.358,88.858,91.36,95.356,97.606,100.495,105.994,110.494,114.49,117.487,121.483,123.733,124.534,131.032,135.028,138.025,142.021,144.271,145.072,149.572,154.072,156.322,157.123,159.625,162.622,166.618,170.614,173.116,180.118,184.114,188.614,191.116,193.366,194.167,198.667,201.169,204.67,208.666,213.166,217.666,220.168,222.67,227.17,231.67,235.666,238.168,240.67,245.17,249.67,253.171,255.421,257.671,258.472,266.473,270.469,274.465,278.965,281.215,282.016,284.518,287.02,294.022,298.018" svgx:width="0.5,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.25,0.55,0.89,0.44,0.44,0.5,0.25,0.55,0.28,0.28,0.78,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">phopenia. There were no treatment discontinuations. Mean time </text>
   <text y="478.044" x="62.362,66.862,71.362,73.468,76.465,78.967,83.467,87.967,92.467,94.969,97.471,104.473,108.973,113.473,115.579,122.077,126.073,129.574,131.68,136.18,140.68,142.93,147.43,149.536,156.538,161.038,165.538,168.04,172.54,176.041,178.291,180.235,185.734,190.234,194.23,195.841,202.339,208.342,214.345,216.451,222.949,226.945,230.446,232.552,237.052,239.302,243.469,247.969,250.219,252.325,256.321,260.821,265.321,267.427,272.926,279.424,284.428,289.432,291.538,295.534,298.036" svgx:width="0.5,0.5,0.25,0.33,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.72,0.67,0.67,0.25,0.72,0.44,0.39,0.25,0.5,0.25,0.5,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">on fingolimod was 24.6 months. The ARR was 0.11, and EDSS at </text>
   <text y="489.042" x="62.362,66.862,69.112,70.219,74.719,78.715,82.711,85.708,89.209,91.459,92.566,95.563,99.559,106.561,110.557,113.059,117.559,121.555,126.055,128.305,129.412,132.913,135.415,139.411,143.911,146.413,150.409,152.659,153.766,156.763,161.263,163.513,168.013,171.01,173.26,175.51,176.617,181.117,185.617,193.114,195.364,196.471,200.971,203.968,206.218,207.325,211.825,215.821,218.323,220.825,224.821,229.321,231.823,235.324,237.574,238.681,243.181,247.177,251.677,253.927,255.034,258.031,262.027,266.527,269.029,273.529,276.031,280.531,285.031,287.533,291.529,295.525,298.027" svgx:width="0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.39,0.28,0.44,0.5,0.28,0.44,0.25,0.55,0.33,0.5,0.25,0.5,0.33,0.25,0.25,0.55,0.5,0.5,0.83,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.33,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">2 years remained stable (3.5). 40% of patients had radiological </text>
   <text y="500.04" x="62.362,66.358,70.354,72.856,75.358,79.858,82.36,84.862,89.362,92.026,96.022,98.524,101.188,108.19,112.69,117.19,119.692,124.192,126.856,131.356,133.606,136.27,141.769,145.765,148.267,152.263,155.26,157.924,162.424,166.924,169.174,171.838,176.338,180.838,183.34,187.84,190.504,195.004,197.668,202.168,206.164,208.666,211.168,215.164,219.664,222.166,224.83,228.331,232.831,237.331,243.829,247.825,252.325,254.989,257.986,261.982,266.482,268.984,273.484,275.986,280.486,284.986,287.488,291.484,295.48,297.982" svgx:width="0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.44,0.28,0.25,0.78,0.5,0.5,0.28,0.5,0.25,0.5,0.25,0.25,0.61,0.44,0.28,0.44,0.33,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.28,0.5,0.25,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.33,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">activity at month 3. Later on, only 1 patient showed radiological </text>
   <text y="511.038" x="62.362,66.358,70.354,72.856,75.358,79.858,82.36,84.862,89.362,91.108,95.104,97.606,99.352,106.354,110.854,115.354,117.856,122.356,124.102,128.602,133.102,135.352,137.098,143.596,148.096,149.842,152.839,156.835,159.337,163.333,167.833,171.829,176.329,178.831,180.577,184.573,189.073,193.573,197.569,200.566,204.067,208.063,209.809,212.806,216.802,220.798,224.794,227.296,229.798,234.298,238.798,242.299,244.045,250.543,254.539,257.536,261.532,263.278,267.778,272.278,275.779,279.775,282.772,287.272,291.268,295.768" svgx:width="0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.44,0.28,0.25,0.78,0.5,0.5,0.28,0.5,0.25,0.5,0.5,0.25,0.25,0.72,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.44,0.33,0.39,0.44,0.25,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">activity at month 24. No relevant adverse reactions were observed.</text>
   <text y="522.036" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="522.036" x="114.193,119.692,124.192,128.188,130.51,133.012,137.512,141.508,144.505,148.501,152.497,155.998,159.994,164.494,166.816,169.813,172.315,175.816,180.316,182.638,187.138,190.135,192.457,197.461,205.462,210.628,212.95,215.452,218.953,221.275,225.775,230.275,234.271,236.593,241.093,244.09,246.412,248.914,253.414,257.41,259.732,266.734,271.234,274.735,277.237,279.559,283.555,288.055,295.057" svgx:width="0.61,0.5,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.56,0.89,0.61,0.25,0.28,0.39,0.25,0.5,0.5,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.78,0.5,0.39,0.28,0.25,0.44,0.5,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The increased risk of PML is one of the most com-</text>
   <text y="533.034" x="62.362,69.364,73.864,78.364,80.614,81.604,84.601,88.597,92.593,96.094,100.594,105.094,108.595,110.845,111.835,114.832,119.332,122.329,124.579,125.569,132.067,137.566,143.065,145.315,146.305,150.805,153.307,156.808,160.804,165.304,169.804,172.306,174.808,179.308,183.808,187.804,190.306,192.808,197.308,201.808,204.058,206.308,207.298,213.796,218.296,220.798,224.794,229.294,231.544,232.534,235.036,238.537,240.787,241.777,245.773,249.274,252.775,257.275,261.271,263.773,267.769,270.271,274.267,278.767,281.017,282.007,288.505,291.007,293.509,298.009" svgx:width="0.78,0.5,0.5,0.25,0.55,0.33,0.44,0.44,0.39,0.5,0.5,0.39,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.72,0.61,0.61,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mon reasons for NTZ discontinuation, which is associated with </text>
   <text y="544.032" x="62.362,66.358,68.86,71.362,75.862,78.364,82.36,86.356,88.858,90.793,94.789,99.289,103.789,105.724,108.721,112.717,117.217,119.719,124.219,126.721,131.221,135.721,138.223,142.219,146.215,148.717,150.652,153.649,157.645,160.147,164.143,168.643,172.144,176.14,178.39,180.325,186.823,191.323,194.32,196.255,200.251,204.751,209.251,213.247,216.244,218.746,222.742,227.242,231.238,235.234,237.169,240.67,245.17,249.67,254.17,258.166,261.667,264.169,267.67,269.605,272.107,276.607,280.603,283.105,285.04,288.037,290.539,295.039" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.25,0.72,0.5,0.33,0.25,0.44,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.44,0.44,0.25,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.39,0.25,0.28,0.5,0.44,0.28,0.25,0.33,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinical and radiological relapse. Our experience suggests that fin-</text>
   <text y="555.03" x="62.362,66.862,71.362,73.864,76.366,83.368,87.868,92.368,95.221,97.723,101.224,104.077,108.073,112.573,115.426,119.422,122.257,125.254,129.25,133.246,135.748,138.25,142.75,146.746,149.599,153.595,156.097,158.599,162.595,165.592,170.092,174.088,176.59,179.092,183.592,187.588,190.441,194.941,199.441,201.943,204.445,208.945,213.445,216.298,219.295,223.795,226.792,229.645,233.641,238.141,242.641,245.143,248.14,252.64,255.142,257.644,260.146,264.646,269.146,271.999,276.499,279.001,282.502,286.498,290.494,293.995,297.991" svgx:width="0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.28,0.39,0.25,0.44,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.28,0.28,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">golimod is an effective alternative option for controlling disease </text>
   <text y="566.028" x="62.362,66.358,70.354,72.856,75.358,79.858,82.36,84.862,89.362,91.612,94.114,98.614,100.864,103.366,107.866,111.862,115.363,119.359,121.609,126.109,130.105,132.607,135.109,139.105,143.605,146.107,149.608" svgx:width="0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">activity in these patients.</text>
   <text y="593.028" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P877</text>
   <text y="604.026" x="62.362,68.86,71.11,76.114,78.616,81.118,85.618,88.615,90.865,94.366,97.363,102.367,107.371,111.871,114.121,117.118,121.618,123.868,128.368,131.869,135.37,139.366,142.867,146.368,148.618,153.622,156.124,159.625,163.621,168.121,171.622,175.618,177.868,181.369,184.366,188.866,191.863,195.859,198.109,201.61,204.607,209.107,214.111,216.613,219.115,221.617,224.614,229.114,231.364,233.614,237.61,240.607,243.604,246.106,250.102,254.602,258.598,263.098,265.348" svgx:width="0.72,0.25,0.56,0.28,0.28,0.5,0.33,0.25,0.39,0.33,0.56,0.56,0.5,0.25,0.33,0.5,0.25,0.5,0.39,0.39,0.44,0.39,0.39,0.25,0.56,0.28,0.39,0.44,0.5,0.39,0.44,0.25,0.39,0.33,0.5,0.33,0.44,0.25,0.39,0.33,0.5,0.56,0.28,0.28,0.28,0.33,0.5,0.25,0.25,0.44,0.33,0.33,0.28,0.44,0.5,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">A pilot study to assess disease state stability, efficacy, </text>
   <text y="615.024" x="62.362,66.862,71.866,76.87,79.12,82.117,86.617,89.119,93.115,97.111,101.611,106.615,109.117,111.619,114.121,117.118,121.618,123.868,126.37,131.374,133.624,138.124,140.374,145.378,149.878,152.875,157.375,159.877,162.379,166.375,171.379,178.876,183.376,188.38,190.63,193.627,198.127,200.377,205.381,207.883,215.38,219.376,222.373,227.377,231.877,234.379,236.629,239.626,244.63,252.127,256.627,260.623,265.123,268.12,272.116" svgx:width="0.5,0.56,0.56,0.25,0.33,0.5,0.28,0.44,0.44,0.5,0.56,0.28,0.28,0.28,0.33,0.5,0.25,0.28,0.56,0.25,0.5,0.25,0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.25,0.33,0.5,0.25,0.56,0.28,0.83,0.44,0.33,0.56,0.5,0.28,0.25,0.33,0.56,0.83,0.5,0.44,0.5,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">and tolerability in a natalizumab to dimethyl fumarate </text>
   <text y="626.022" x="62.362,66.358,70.354,74.854,78.355,81.856,86.356,90.856,94.852,98.848,101.098,106.102,110.098,113.599,116.101,120.601" svgx:width="0.44,0.44,0.5,0.39,0.39,0.5,0.5,0.44,0.44,0.25,0.56,0.44,0.39,0.28,0.5,0.56" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">crossover design</text>
   <text y="637.02" x="62.362,65.863,70.867,73.117,78.121,82.621,85.123,89.119" svgx:width="0.39,0.56,0.25,0.56,0.5,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">JF Foley</text>
   <text y="634.592" x="93.619" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="637.112" x="96.544,98.794,101.044,106.543,108.793,115.291,119.791,124.291" svgx:width="0.25,0.25,0.61,0.25,0.72,0.5,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Hoyt</text>
   <text y="634.592" x="126.793" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="637.112" x="129.718,131.968,134.218,140.716,142.966,148.969,153.469,156.466,158.968,162.469,164.971,168.967,173.467,176.968,180.964" svgx:width="0.25,0.25,0.72,0.25,0.67,0.5,0.33,0.28,0.39,0.28,0.44,0.5,0.39,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Christensen</text>
   <text y="634.592" x="185.463" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="637.112" x="188.388,190.638,192.888,199.386,201.636,207.639,210.141,214.137,216.639,219.141,223.137" svgx:width="0.25,0.25,0.72,0.25,0.67,0.28,0.44,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Blatter</text>
   <text y="634.592" x="226.134" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="645.59" x="62.363" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="648.112" x="65.287,70.786,75.286,79.282,83.278,87.274,89.524,97.021,101.521,106.021,110.521,113.023,117.523,120.025,124.525,126.775,134.272,138.772,141.022,146.521,150.517,154.018,158.014,162.514,166.015,170.011,174.511,176.761,183.259,186.76,191.26,195.76,200.26,202.51,204.76,209.26,213.76,216.262,218.764,221.014,226.018,230.518,234.514,238.51,240.76,246.763,249.265,251.767,255.763,258.013,260.263,266.761,271.765,274.015" svgx:width="0.61,0.5,0.44,0.44,0.44,0.25,0.83,0.5,0.5,0.5,0.28,0.5,0.28,0.5,0.25,0.83,0.5,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25,0.72,0.39,0.5,0.5,0.5,0.25,0.25,0.5,0.5,0.28,0.28,0.25,0.56,0.5,0.44,0.44,0.25,0.67,0.28,0.28,0.44,0.25,0.25,0.72,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Rocky Mountain MS Research Group, Salt Lake City, UT, </text>
   <text y="659.11" x="62.362,68.86,73.36,75.862,78.364,82.36,86.86,89.11,93.61,96.112,100.612,103.114,107.11,110.611,112.861" svgx:width="0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">United States, </text>
   <text y="656.592" x="115.111" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="659.112" x="118.036,125.533,130.033,134.533,139.033,141.535,146.035,148.537,153.037,155.287,162.784,166.78,171.28,173.782,177.778,182.278,184.78,187.03,192.529,197.029,201.025,204.526,207.028,211.024,213.526,218.026,222.526,224.776,229.276,233.776,237.772,241.768,244.27,248.77,251.272,253.774,257.275,259.777,263.278,265.528,267.778,272.278,276.778,279.28,281.782" svgx:width="0.83,0.5,0.5,0.5,0.28,0.5,0.28,0.5,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.61,0.5,0.44,0.39,0.28,0.44,0.28,0.5,0.5,0.25,0.5,0.5,0.44,0.44,0.28,0.5,0.28,0.28,0.39,0.28,0.39,0.25,0.25,0.5,0.5,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Mountain Medical Physician Specialists, Salt </text>
   <text y="670.11" x="62.362,67.366,71.866,75.862,79.858,82.108,88.111,90.613,93.115,97.111,99.361,101.611,108.109,113.113,115.363,117.613,124.111,128.611,131.113,133.615,137.611,142.111,144.361,148.861,151.363,155.863,158.365,162.361" svgx:width="0.56,0.5,0.44,0.44,0.25,0.67,0.28,0.28,0.44,0.25,0.25,0.72,0.56,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Lake City, UT, United States</text>
   <text y="697.11" x="62.362,68.5,73.135,77.266,82.405,87.04,91.009,95.644,100.783,105.922,111.061,114.193" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="697.11" x="117.019,125.65,130.285,132.922,135.559,139.69,142.516,147.151,151.282,153.919,158.05,160.687,163.324,167.455,172.09,179.227,183.358,187.993,190.819,193.456,198.091,202.222,205.354,209.485,214.12,218.755,221.581,224.218,227.854,230.68,235.315,237.952,242.587,247.222,249.859,254.494,257.32,261.451,264.421,267.553,270.19,274.321,278.452,282.583,285.22,289.855,294.49,297.991" svgx:width="0.94,0.5,0.28,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.28,0.39,0.25,0.5,0.28,0.5,0.5,0.28,0.5,0.25,0.44,0.33,0.33,0.28,0.44,0.44,0.44,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">While natalizumab therapy is highly efficacious </text>
   <text y="708.108" x="62.362,65.494,70.129,73.261,75.511,76.24,78.877,83.512,87.643,89.893,90.622,93.259,96.391,100.522,104.653,107.29,114.427,118.558,123.193,125.83,128.07999999999998,128.809,133.444,136.576,138.826,139.555,146.692,151.327,153.964,156.601,159.238,163.873,166.51,170.641,172.891,173.62,177.256,181.387,184.024,188.155,191.287,195.922,199.558,202.195,205.831,208.081,208.81,211.942,220.078,225.217,228.349,230.734,232.984,233.713,236.35,238.987,241.237,241.966,246.601,251.236,255.367,259.003,261.253,261.982,266.113,270.244,273.376,276.508,281.143,283.393,284.122,287.758,290.395,295.03" svgx:width="0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.89,0.56,0.33,0.25,0.25,0.55,0.28,0.28,0.25,0.55,0.5,0.5,0.44,0.39,0.25,0.55,0.44,0.44,0.33,0.33,0.5,0.25,0.55,0.39,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">for the treatment of multiple sclerosis (MS), it does carry sig-</text>
   <text y="719.106" x="62.362,66.997,69.634,72.766,75.403,79.534,83.665,88.3,90.937,93.187,95.32,98.452,101.089,104.725,109.36,111.61,113.743,116.875,121.51,124.642,126.892,129.025,133.66,136.792,141.427,146.062,149.194,153.325,156.961,160.597,163.234,167.869,172.0,174.25,176.383,183.52,188.155,190.792,193.429,196.066,199.198,203.833,207.964,212.095,214.732,216.982,219.115,221.752,225.883,230.518,235.153,239.788,243.919,248.554,252.685,256.816,261.451,266.086,270.217,272.854,277.489,282.124,286.255,288.892,293.527,298.027" svgx:width="0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.55,0.33,0.28,0.39,0.5,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.55,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nificant risk for progressive multifocal leukoencephalopathy </text>
   <text y="730.104" x="62.362,65.494,70.633,78.769,84.403,87.535,89.785,91.819,94.456,99.091,101.341,103.384,108.019,112.15,114.787,117.424,121.555,126.19,128.827,132.463,134.713,136.756,143.389,148.024,152.659,154.909,156.943,161.578,165.709,170.344,174.475,176.725,178.768,182.899,187.534,189.784,191.818,194.455,201.592,208.729,213.364,217.999,222.634,226.27,230.905,235.54,240.175,243.307,247.438,251.074,254.71,258.841,263.476,266.113,268.363,270.397,275.032,277.669,281.305,283.942,288.577,291.709,295.759,298.009" svgx:width="0.33,0.56,0.89,0.61,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.44,0.5,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.5,0.28,0.25,0.55,0.5,0.28,0.39,0.28,0.5,0.33,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(PML) in patients who have an immunosuppressant history, </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 429.300 L358.750 429.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,315.092,320.168,324.668,329.168,331.499,335.999,339.995,342.497,346.493,348.995,351.497,355.493,359.993,366.995,370.991,375.491,377.822,382.322,386.822,390.323,394.319,397.82,400.07,402.401,406.397,410.897,415.397,417.728,421.229,427.232,433.568,435.899,438.401,442.901,447.401,451.397,455.897,458.228,462.728,465.725,468.056,473.132,478.208,482.708,484.958,489.458,491.708,493.544,499.547,501.878,505.874,508.871,513.371,516.872,520.373,524.873,529.373,533.369,536.366,538.697,541.199,545.699" svgx:width="0.56,0.56,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.5,0.5,0.39,0.44,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.39,0.67,0.72,0.25,0.28,0.5,0.5,0.44,0.5,0.25,0.5,0.33,0.25,0.56,0.56,0.5,0.25,0.5,0.25,0.25,0.72,0.25,0.44,0.33,0.5,0.39,0.39,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">&gt;=24 natalizumab doses, and JCV index of &gt;=1.5. A crossover to </text>
   <text y="88.101" x="310.016,314.516,317.018,324.02,328.016,330.518,335.018,339.518,342.02,344.216,347.213,351.713,358.715,362.711,365.708,369.704,372.206,376.202,378.398,381.395,387.893,395.894,400.898,403.895,406.091,408.593,412.094,414.29,418.286,422.786,424.982,429.482,433.982,436.484,438.986,443.486,447.986,450.182,453.179,457.679,460.676,462.872,469.874,473.87,478.37,482.87,485.066,489.566,492.563,494.759,497.261,501.761,505.757,509.258,513.254,515.45,519.95,523.946,526.448,528.95,532.946,537.446,539.948,543.449,545.699" svgx:width="0.5,0.28,0.78,0.44,0.28,0.5,0.5,0.28,0.25,0.33,0.5,0.78,0.44,0.33,0.44,0.28,0.44,0.25,0.33,0.72,0.89,0.56,0.33,0.25,0.28,0.39,0.25,0.44,0.5,0.25,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.33,0.25,0.78,0.44,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">dimethyl fumarate (DMF) is an option for many of these patients. </text>
   <text y="99.099" x="310.016,315.515,320.015,324.011,326.261,330.761,334.757,337.259,341.255,343.505,346.502,350.498,354.998,358.994,361.991,366.491,368.993,373.493,377.993,380.243,384.239,386.489,390.485,393.482,397.982,401.483,404.984,409.484,413.984,417.98,420.977,423.227,427.727,430.724,432.974,435.476,439.976,442.478,445.979,448.229,452.729,456.725,459.227,463.727,466.724,470.72,472.97,477.47,481.97,485.966,489.467,491.717,496.217,500.717,503.219,505.469,509.969,513.965,516.467,518.717,522.713,527.213,529.715,533.216,535.718" svgx:width="0.61,0.5,0.44,0.25,0.5,0.44,0.28,0.44,0.25,0.33,0.44,0.5,0.44,0.33,0.5,0.28,0.5,0.5,0.25,0.44,0.25,0.44,0.33,0.5,0.39,0.39,0.5,0.5,0.44,0.33,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.5,0.44,0.28,0.5,0.33,0.44,0.25,0.5,0.5,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.5,0.44,0.28,0.25,0.44,0.5,0.28,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The data regarding a crossover of this nature does not yet exist.</text>
   <text y="110.097" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="110.097" x="355.151,360.02,364.52,366.167,370.667,374.663,377.165,381.161,384.158,391.16,393.662,398.162,402.158,403.805,408.305,410.807,414.308,418.304,422.3,425.801,429.797,431.444,434.945,437.447,441.443,445.943,448.445,450.947,453.449,455.951,460.451,462.098,465.095,469.595,472.592,474.239,478.739,483.239,484.886,491.384,495.38,499.376,503.876,507.377,509.024,511.526,516.026,517.673,522.173,526.169,528.671,531.173,535.169,539.669,542.171,545.672" svgx:width="0.61,0.5,0.25,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To determine disease stability for 24 weeks in patients </text>
   <text y="121.095" x="310.016,316.514,321.014,325.514,327.764,328.979,333.479,337.475,341.975,345.971,348.221,349.436,353.432,356.429,360.929,364.43,367.931,371.927,376.427,378.677,379.892,384.392,388.892,392.888,395.885,398.135,399.35,402.347,405.344,409.844,416.846,419.096,420.311,424.811,428.807,431.309,435.305,437.807,440.309,444.305,448.805,455.807,459.803,464.303,466.553,467.768,470.27,474.77,477.02,478.235,482.735,485.237,492.239,496.235,498.737,503.237,507.737,510.239,512.489,513.704,516.701,521.201,528.203,532.199,535.196,539.192,541.694,545.69" svgx:width="0.72,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.44,0.33,0.5,0.39,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.44,0.33,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.78,0.44,0.28,0.5,0.5,0.28,0.25,0.55,0.33,0.5,0.78,0.44,0.33,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">who have crossed over from natalizumab to dimethyl fumarate </text>
   <text y="132.093" x="310.016,312.518,317.018,321.014,324.011,328.007,332.507,336.422" svgx:width="0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">therapy.</text>
   <text y="143.091" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="143.091" x="348.338,352.838,357.338,359.165,362.666,367.166,371.666,374.168,378.164,382.16,384.662,388.163,389.99,393.986,396.488,398.315,402.815,405.317,409.817,414.317,416.144,419.141,421.643,425.144,429.644,431.471,434.468,439.544,444.044,445.871,450.371,454.367,458.363,461.36,464.861,466.688,471.188,475.688,477.515,480.017,484.517,488.513,491.51,495.506,500.006,503.921,506.171,507.998,511.499,517.502,523.838,525.665,528.167,532.667,537.167,541.163,545.663" svgx:width="0.5,0.5,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.44,0.28,0.25,0.5,0.28,0.5,0.5,0.25,0.33,0.28,0.39,0.5,0.25,0.33,0.56,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.25,0.39,0.67,0.72,0.25,0.28,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">30 subjects at high risk (&gt;2 years on therapy, JCV index </text>
   <text y="154.089" x="310.016,315.092,320.168,322.418,323.327,327.827,330.077,334.577,337.574,339.824,340.733,343.73,348.23,351.227,353.477,354.386,358.886,362.882,367.382,371.378,373.88,378.38,382.88,385.382,389.882,394.382,396.632,397.541,402.545,410.546,415.712,417.962,418.871,423.371,427.871,430.121,431.03,435.53,439.526,442.028,446.024,448.526,451.028,455.024,459.524,466.526,470.522,475.022,477.272,478.181,484.679,488.675,491.672,495.668,497.918,498.827,502.823,507.323,510.32,514.82,517.322,519.824,523.82,528.32,530.57,531.479,533.981,538.481,540.731,541.64,545.636" svgx:width="0.56,0.56,0.25,0.55,0.5,0.25,0.5,0.33,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.56,0.89,0.61,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.5,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">&gt;= 1.5) for developing PML on natalizumab were enrolled in a </text>
   <text y="165.087" x="310.016,313.517,316.019,320.519,325.019,329.519,331.769,333.065,335.567,340.067,342.317,343.613,350.615,355.115,359.615,362.117,364.619,369.119,372.116,374.366,375.662,378.164,382.664,386.66,389.162,392.159,394.409,395.705,398.207,401.204,405.2,409.7,413.201,415.703,418.205,420.707,425.207,429.707,431.957,433.253,435.755,440.255,442.505,443.801,448.301,450.803,457.805,461.801,464.303,468.803,473.303,475.805,478.055,479.351,482.348,486.848,493.85,497.846,500.843,504.839,507.341,511.337,513.587,515.837,517.133,522.137,526.133,528.635,531.137,535.133,539.633,542.135,545.636" svgx:width="0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.28,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.28,0.33,0.25,0.55,0.28,0.33,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.78,0.44,0.28,0.5,0.5,0.28,0.25,0.55,0.33,0.5,0.78,0.44,0.33,0.44,0.28,0.44,0.25,0.25,0.55,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">study to monitor their transition to dimethyl fumarate. Patients </text>
   <text y="176.085" x="310.016,316.514,320.51,323.507,327.503,329.411,333.911,338.411,341.912,345.908,348.905,353.405,357.401,361.901,363.809,366.806,371.306,374.303,376.211,380.711,385.211,387.119,393.617,397.613,401.609,406.109,409.61,411.86,413.768,417.269,419.771,423.767,426.764,429.266,431.768,436.268,440.768,442.676,445.673,448.67,453.17,460.172,462.08,464.582,469.082,473.078,475.58,478.577,480.485,482.987,486.983,490.484,492.986,494.894,499.394,503.894,507.395,511.391,513.299,517.799,520.796,522.704,527.204,531.2,533.702,537.698,540.2,542.702" svgx:width="0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.5,0.25,0.72,0.44,0.44,0.5,0.39,0.25,0.25,0.39,0.28,0.44,0.33,0.28,0.28,0.5,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.28,0.33,0.25,0.28,0.44,0.39,0.28,0.25,0.5,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were observed for 24 weeks, starting from their last dose of natali-</text>
   <text y="187.083" x="310.016,314.012,318.512,325.514,329.51,334.01,336.26,339.095,341.597,346.097,350.093,353.09,357.086,361.586,365.501,367.751,370.001,372.836,379.334,383.834,386.336,390.332,394.832,401.834,405.83,408.08,410.915,417.917,421.913,425.909,429.41,433.91,436.907,440.903,444.404,446.654,449.489,451.991,456.491,460.487,462.989,467.489,471.989,475.985,480.485,482.735,485.57,490.07,492.572,496.073,500.069,504.065,507.566,511.562,513.812,516.647,520.148,522.65,526.646,531.146,533.648,536.15,538.652,541.154,545.654" svgx:width="0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.25,0.55,0.72,0.5,0.28,0.44,0.5,0.78,0.44,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zumab therapy. Outcome measures included disease stability </text>
   <text y="198.081" x="310.016,314.516,318.512,321.509,324.011,328.511,332.507,337.007,339.257,342.389,346.889,351.389,353.639,356.771,362.27,368.768,373.772,378.776,381.026,383.276,386.408,390.404,394.904,399.404,403.904,407.9,410.402,412.904,416.9,420.896,425.396,427.646,430.778,433.775,437.771,440.273,444.269,448.769,452.27,456.266,458.516,461.648,464.645,468.641,471.143,475.139,477.389,479.639,482.771,489.773,494.273,498.773,501.275,504.272,506.774,510.77,515.27,517.52,520.652,523.649,527.645,530.147,532.649,537.149,541.649,545.645" svgx:width="0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.61,0.72,0.56,0.56,0.25,0.25,0.55,0.44,0.5,0.5,0.5,0.44,0.28,0.28,0.44,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.55,0.33,0.44,0.28,0.44,0.25,0.25,0.55,0.78,0.5,0.5,0.28,0.33,0.28,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.28,0.5,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">defined by EDSS, annualized relapse rate, modified fatigue </text>
   <text y="209.079" x="310.016,312.518,319.52,324.02,328.016,332.012,334.514,336.278,339.779,343.775,347.771,350.273,354.269,356.033,359.03,367.031,372.035,375.032,380.036,383.033,384.797,388.793,393.293,397.793,399.557,402.059,406.559,410.555,412.319,415.82,420.32,427.322,431.822,436.322,438.824,440.588,445.088,447.59,452.09,454.592,457.094,458.858,465.86,470.36,474.86,478.856,481.358,483.86,486.362,488.864,492.86,496.361,498.125,500.627,504.623,508.124,510.626,512.39,515.387,520.391,526.889,534.89,540.389,543.386,545.636" svgx:width="0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.39,0.44,0.44,0.28,0.44,0.25,0.33,0.89,0.56,0.33,0.56,0.33,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.78,0.5,0.5,0.28,0.25,0.5,0.28,0.5,0.28,0.28,0.25,0.78,0.5,0.5,0.44,0.28,0.28,0.28,0.28,0.44,0.39,0.25,0.28,0.44,0.39,0.28,0.25,0.33,0.56,0.72,0.89,0.61,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">impact scale (MFIS) and the symbol digit modalities test (SDMT), </text>
   <text y="220.077" x="310.016,314.516,317.018,320.519,325.019,329.015,331.517,333.362,337.358,341.858,345.854,348.356,352.856,357.356,359.201,362.702,366.698,370.694,373.196,377.192,379.046,382.043,387.38,393.878,398.882,401.879,404.129,405.983,409.979,414.479,418.979,420.824,423.326,425.828,432.83,436.826,441.326,443.18,447.68,452.18,454.025,457.022,461.522,466.022,468.524,470.369,476.867,480.863,483.365,487.865,489.719,492.221,496.217,499.718,502.22,504.47,506.315,514.316,520.319,523.316,525.161,529.157,533.153,535.655,538.157,542.657" svgx:width="0.5,0.28,0.39,0.5,0.44,0.28,0.25,0.44,0.5,0.44,0.28,0.5,0.5,0.25,0.39,0.44,0.44,0.28,0.44,0.25,0.33,0.72,0.72,0.56,0.33,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.28,0.78,0.44,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.5,0.28,0.25,0.72,0.44,0.28,0.5,0.25,0.28,0.44,0.39,0.28,0.25,0.25,0.89,0.67,0.33,0.25,0.44,0.44,0.28,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">visual analog scale (VAS), and timed 25 foot walk test. MRI activ-</text>
   <text y="231.075" x="310.016,312.518,315.02,319.52,321.77,323.57,326.072,330.572,334.568,337.07,341.57,346.07,348.572,353.072,357.572,359.822,361.622,365.123,369.623,373.619,377.615,380.117,383.114,387.614,391.115,395.111,399.611,404.111,408.611,410.861,412.661,419.159,423.155,426.656,428.906,430.706,437.708,441.704,445.7,449.201,453.701,456.698,460.694,465.194,467.444,469.244,473.24,475.742,477.992,479.63,487.406,491.402,495.398,499.898,502.148,503.948,508.448,510.698,512.948,514.586,522.362,526.358,530.354,534.854,537.104,538.904,543.404,545.654" svgx:width="0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.39,0.5,0.44,0.44,0.28,0.33,0.5,0.39,0.44,0.5,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.94,0.44,0.44,0.5,0.25,0.55,0.5,0.25,0.25,0.55,0.94,0.44,0.44,0.5,0.25,0.55,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ity including spectroscopy was measured at Week 0, Week 4, </text>
   <text y="242.073" x="310.016,317.792,321.788,325.784,330.284,332.534,337.034,341.534,343.784,346.034,350.03,354.53,359.03,361.118,368.894,372.89,376.886,381.386,383.636,388.136,392.636" svgx:width="0.94,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.94,0.44,0.44,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Week 16, and Week 24.</text>
   <text y="253.071" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="253.071" x="343.568,350.066,353.063,355.619,358.121,362.621,366.617,369.173,373.673,378.173,380.729,385.229,389.225,391.727,394.229,398.225,402.725,405.227,408.728,411.284,417.782,422.282,426.782,429.338,433.838,437.834,442.334,446.33,448.886,452.882,457.382,464.384,468.884,471.386,475.382,477.884,481.88,486.38,488.927,491.429,495.929,499.925,502.481,505.982,508.484,512.984,517.484,521.399,523.649,526.196,533.198,537.194,541.19,545.69" svgx:width="0.72,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.78,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Of the 15 patients who have completed the study, mean </text>
   <text y="264.069" x="310.016,318.017,323.021,325.685,330.185,332.687,336.188,340.184,344.18,347.681,351.677,354.341,358.841,363.341,366.338,370.334,372.836,375.338,379.838,384.338,387.002,393.5,397.496,400.997,403.661,408.161,412.661,415.325,419.825,423.821,427.817,430.814,434.315,436.565,439.229,446.231,450.227,454.223,458.723,461.387,465.887,470.387,477.389,481.889,485.885,488.882,491.546,496.046,499.043,501.707,506.207,510.203,512.705,516.701,519.203,521.705,525.701,530.201,537.203,541.199,545.699" svgx:width="0.89,0.56,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.78,0.44,0.44,0.5,0.25,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS disease duration was 16 years, mean number of natalizumab </text>
   <text y="275.067" x="310.016,312.518,317.018,320.015,324.515,328.016,330.518,335.018,339.518,343.019,345.017,351.515,355.511,359.012,361.001,365.501,370.001,372.251,374.249,378.245,382.745,387.245,389.243,391.745,396.245,400.241,402.23,409.232,413.228,417.224,421.724,423.722,426.224,430.22,434.72,439.22,441.722,446.222,448.211,452.711,455.708,457.706,460.208,464.708,468.704,470.702,473.204,477.2,480.701,483.203,485.192,489.692,491.69,494.192,498.692,501.689,506.189,509.69,512.192,516.692,521.192,523.19,527.186,531.686,535.682,538.184,542.18,545.681" svgx:width="0.28,0.5,0.33,0.5,0.39,0.28,0.5,0.5,0.39,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.28,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.39,0.28,0.25,0.5,0.25,0.28,0.5,0.33,0.5,0.39,0.28,0.5,0.5,0.25,0.44,0.5,0.44,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">infusions was 67, and the mean length of the last 6 infusion cycles </text>
   <text y="286.065" x="310.016,316.514,320.51,324.011,326.18,330.68,335.18,337.349,341.849,345.845,350.345,353.846,356.096,358.265,363.269,366.266,370.766,377.768,379.937,382.439,386.939,390.935,393.104,397.604,401.6,404.102,408.098,410.267,414.767,417.764,419.933,422.435,426.935,430.931,433.1,435.602,439.598,443.099,445.601,447.77,450.272,454.772,457.769,462.269,465.77,468.272,472.772,477.272,479.522,481.691,484.193,486.695,488.864,491.366,495.866,500.366,504.866,507.035,511.031,515.531,517.7,521.696,526.196,530.192,533.189,537.185,541.685,545.681" svgx:width="0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.44,0.5,0.39,0.25,0.25,0.56,0.33,0.5,0.78,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.39,0.28,0.25,0.28,0.5,0.33,0.5,0.39,0.28,0.5,0.5,0.25,0.25,0.28,0.28,0.25,0.28,0.5,0.5,0.5,0.25,0.44,0.5,0.25,0.44,0.5,0.44,0.33,0.44,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was 37 days. From the date of the last infusion, it took an average </text>
   <text y="297.063" x="310.016,314.516,317.513,319.547,324.047,328.547,330.581,335.081,339.077,343.577,347.078,349.112,351.614,356.114,358.148,362.648,366.644,371.144,373.646,378.146,380.18,382.682,387.182,391.178,393.212,397.712,402.212,406.712,408.746,415.748,420.248,422.282,426.782,431.282,434.783,438.779,440.813,445.313,448.31,450.344,456.842,464.843,469.847,471.881,475.877,480.377,484.877,486.911,490.907,495.407,499.907,502.409,506.909,510.905,513.902,515.936,520.436,522.686,527.186,529.22,533.72,537.716,542.216,545.717" svgx:width="0.5,0.33,0.25,0.5,0.5,0.25,0.5,0.44,0.5,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.5,0.25,0.78,0.5,0.25,0.5,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.72,0.89,0.56,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.44,0.33,0.25,0.5,0.25,0.5,0.25,0.5,0.44,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of 22 days to begin the 120 mg dose of DMF and another 6.8 days </text>
   <text y="308.061" x="310.016,312.518,317.018,319.268,320.042,322.544,325.046,327.548,330.545,334.541,337.043,341.039,343.289,344.063,346.565,351.065,353.315,354.089,356.591,361.091,365.087,367.337,368.111,372.611,377.111,381.611,383.861,384.635,391.637,396.137,398.387,399.161,403.661,408.161,411.662,415.658,417.908,420.437,426.935,429.437,431.687,432.461,436.961,440.957,444.458,448.454,450.956,453.458,457.958,461.954,464.204,466.454,467.228,469.73,474.23,478.226,480.476,481.25,484.751,490.754,497.09,499.34,500.114,502.616,507.116,511.616,515.612,520.112,522.362,523.136,526.637,530.633,535.133,538.13,542.126,545.627" svgx:width="0.28,0.5,0.25,0.55,0.28,0.28,0.28,0.33,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.78,0.5,0.25,0.55,0.5,0.5,0.39,0.44,0.25,0.25,0.72,0.28,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.67,0.72,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.39,0.44,0.5,0.33,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">to titrate to the 240 mg dose. At baseline, the JCV index scores </text>
   <text y="319.059" x="310.016,313.013,317.009,321.509,326.009,330.005,334.505,336.395,339.392,342.389,346.889,353.891,355.781,360.281,362.531,367.031,371.531,374.528,379.028,381.278,385.778,390.278,392.528,394.418,399.917,406.415,411.419,416.423,418.313,421.814,425.81,430.31,433.307,437.303,439.193,441.695,446.195,450.191,453.188,457.184,461.18,464.681,468.677,473.177,475.067,479.567,484.067,485.957,490.457,492.707,497.207,499.097,501.599,506.099,507.989,512.489,514.379,518.879,521.876,523.766,526.268,530.768,534.764,536.654,541.154,545.654" svgx:width="0.33,0.44,0.5,0.5,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.25,0.5,0.5,0.33,0.5,0.25,0.5,0.5,0.25,0.25,0.61,0.72,0.56,0.56,0.25,0.39,0.44,0.5,0.33,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.25,0.5,0.25,0.28,0.5,0.25,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ranged from 1.24-3.95. EDSS score increased by 0.5 in 4 of the 15 </text>
   <text y="330.057" x="310.016,313.517,318.017,322.517,325.019,329.015,333.011,335.513,339.014,341.264,343.847,349.346,353.846,358.346,361.847,364.592,367.589,371.585,374.222,376.472,379.217,383.717,386.462,390.962,393.959,396.704,399.206,403.706,407.702,410.447,414.947,419.447,422.192,425.693,430.193,434.693,437.195,441.191,445.187,447.689,451.19,453.935,458.435,462.431,466.931,470.927,473.672,476.174,479.171,483.167,487.667,491.168,493.67,496.172,498.674,503.174,507.674,511.67,516.17,518.915,523.415,527.411,531.407,535.907,538.652,541.154,545.654" svgx:width="0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.25,0.61,0.5,0.5,0.39,0.25,0.33,0.44,0.33,0.25,0.25,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.25,0.39,0.5,0.5,0.28,0.44,0.44,0.28,0.39,0.25,0.5,0.44,0.5,0.44,0.25,0.28,0.33,0.44,0.5,0.39,0.28,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.5,0.44,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">subjects. Thus far, 2 of the 15 subjects have transitioned back to </text>
   <text y="341.055" x="310.016,314.516,318.512,321.014,325.01,327.512,330.014,334.01,338.51,345.512,349.508,354.008" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">natalizumab.</text>
   <text y="352.053" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="352.053" x="362.819,368.318,372.818,376.814,379.064,380.108,384.608,388.604,391.106,395.102,397.352,398.396,400.898,405.398,409.394,413.894,416.144,417.188,421.184,425.684,432.686,437.186,439.688,443.684,446.186,448.688,453.188,457.688,459.938,460.982,463.484,467.984,471.98,474.23,475.274,478.775,481.277,485.777,490.277,494.777,497.027,498.071,504.569,507.071,509.573,512.075,514.325,515.369,519.869,523.865,527.861,532.361,535.358,537.608,538.652,541.154,545.654" svgx:width="0.61,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.28,0.25,0.55,0.5,0.44,0.44,0.5,0.33,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The data lock completing the study will occur in </text>
   <text y="363.051" x="310.016,316.514,321.014,325.514,330.014,333.515,336.017,338.267,342.767,345.764,348.014,352.514,357.014,361.514,366.014,368.264,370.019,376.517,379.019,381.521,383.771,388.271,392.771,395.273,399.269,403.769,410.771,414.767,417.017,424.019,428.015,432.011,435.512,440.012,443.009,447.005,450.506,452.756,459.254,461.756,464.258,466.76,469.01,473.51,477.506,479.756,484.256,487.253,491.249,494.75,498.746,503.246,505.748,509.744,514.244" svgx:width="0.72,0.5,0.5,0.5,0.39,0.28,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.72,0.28,0.28,0.25,0.5,0.5,0.28,0.44,0.5,0.78,0.44,0.25,0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.39,0.25,0.72,0.28,0.28,0.28,0.25,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">August of 2014. All outcome measures will be presented.</text>
   <text y="395.055" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P878</text>
   <text y="406.053" x="310.016,317.018,319.52,324.02,329.024,331.274,334.775,338.771,342.767,347.267,351.263,355.763,360.767,365.267,369.263,373.259,376.76,379.262,383.762,388.766,391.016,393.518,398.522,400.772,405.272,407.522,411.518,416.018,421.022,425.522,429.518,432.515,434.765,443.261,448.265,450.515,455.519,460.019,463.016,465.518,469.514,474.518,477.515,481.016,483.266,486.263,490.259,494.255,498.755,501.752,505.748,510.752" svgx:width="0.78,0.28,0.5,0.56,0.25,0.39,0.44,0.44,0.5,0.44,0.5,0.56,0.5,0.44,0.44,0.39,0.28,0.5,0.56,0.25,0.28,0.56,0.25,0.5,0.25,0.44,0.5,0.56,0.5,0.44,0.33,0.25,0.94,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.25,0.33,0.44,0.44,0.5,0.33,0.44,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">High seroconversion in a cohort MS patients treated </text>
   <text y="417.051" x="310.016,316.514,319.016,322.013,327.017,329.267,334.271,338.771,341.768,346.268,348.77,351.272,355.268,360.272,367.769,372.269,377.273,379.523,382.025,387.029,389.279,395.777,403.274,406.775,409.772,413.768,417.764,422.768,427.268" svgx:width="0.72,0.28,0.33,0.56,0.25,0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.25,0.28,0.56,0.25,0.72,0.83,0.39,0.33,0.44,0.44,0.56,0.5,0.83" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">with natalizumab in Amsterdam</text>
   <text y="428.049" x="310.016,316.514,318.764,325.262,329.258,333.758,338.258,342.254,346.754,351.254,355.754" svgx:width="0.72,0.25,0.72,0.44,0.5,0.5,0.44,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">A Vennegoor</text>
   <text y="425.583" x="358.75" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="428.103" x="361.675,363.925,366.175,369.676,376.174,378.424,384.427,388.927,392.428,395.929,400.429" svgx:width="0.25,0.25,0.39,0.72,0.25,0.67,0.5,0.39,0.39,0.5,0.78" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, JA Rossum</text>
   <text y="425.583" x="407.431" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="428.103" x="410.356,412.606,414.856,422.857,427.861,430.111,438.607,442.603,445.105,447.607,450.109,454.105" svgx:width="0.25,0.25,0.89,0.56,0.25,0.94,0.44,0.28,0.28,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, MP Wattjes</text>
   <text y="425.583" x="457.605" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="428.103" x="460.53,462.78,465.03,468.531,470.781,477.279,479.781,482.283,484.785,488.781,492.282,494.784,498.78,501.282" svgx:width="0.25,0.25,0.39,0.25,0.72,0.28,0.28,0.28,0.44,0.39,0.28,0.44,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Killestein</text>
   <text y="425.583" x="505.782" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="436.581" x="310.017" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="439.103" x="312.941,318.44,324.938,327.188,334.685,338.681,343.181,345.683,349.679,354.179,356.681,358.931,364.934,368.93,373.43,375.932,379.928,383.429,385.679,387.929,393.428,399.926,403.427,405.929,409.925,413.426,417.926,422.426,428.924,431.174,433.424,439.427,443.423,445.925,450.425,454.421,457.922,460.424,464.924,469.424,473.924" svgx:width="0.61,0.72,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.61,0.72,0.39,0.28,0.44,0.39,0.5,0.5,0.72,0.25,0.25,0.67,0.44,0.28,0.5,0.44,0.39,0.28,0.5,0.5,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">VU Medical Center, Amsterdam, Netherlands</text>
   <text y="466.103" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="466.103" x="363.62,367.121,371.621,376.121,380.621,382.871,383.879,389.882,394.382,398.882,403.382,405.884,410.384,414.884,419.384,423.38,430.382,432.632,433.64,438.14,440.642,443.639,448.139,451.64,453.89,454.898,457.895,461.396,467.399,473.897,476.894,479.144,480.152,483.653,487.649,490.646,495.146,499.646,504.146,507.647,510.149,512.651,515.153,519.653,522.155,524.657,529.157,531.407,532.415,534.917,538.418,540.668,541.676,545.672" svgx:width="0.39,0.5,0.5,0.5,0.25,0.55,0.67,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.44,0.78,0.25,0.55,0.5,0.28,0.33,0.5,0.39,0.25,0.55,0.33,0.39,0.67,0.72,0.33,0.25,0.55,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">John Cunningham virus (JCV) seropositivity is a </text>
   <text y="477.101" x="310.016,313.013,315.515,319.016,323.516,325.478,328.475,332.471,336.467,338.969,343.469,346.466,348.428,351.425,355.925,358.922,360.884,363.386,367.886,371.882,373.844,378.344,382.34,386.84,390.836,393.338,397.838,402.338,409.34,413.336,417.836,420.338,422.3,426.8,429.797,431.759,436.259,439.256,443.756,448.256,451.253,455.249,458.75,462.251,464.753,469.253,473.249,475.211,482.213,486.713,489.215,491.717,494.219,497.216,501.716,505.712,509.708,512.21,514.172,516.674,520.67,525.17,529.67,534.17,538.166,542.666" svgx:width="0.33,0.28,0.39,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.5,0.33,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">risk factor for the development of progressive multifocal leukoen-</text>
   <text y="488.099" x="310.016,314.012,318.008,322.508,327.008,331.004,333.506,338.006,342.506,346.502,349.004,353.504,358.004,360.254,362.117,365.114,370.118,378.119,383.618,386.615,388.865,390.728,395.228,399.728,402.725,405.227,409.727,414.227,416.477,418.34,422.84,426.836,429.338,433.334,435.836,438.338,442.334,446.834,453.836,457.832,462.332,464.582,466.445,468.947,471.944,475.94,479.936,482.438,489.44,493.436,497.936,500.438,502.688,504.551,507.053,511.553,513.803,515.666,522.668,527.168,529.67,532.172,534.674,539.174,541.676,545.672" svgx:width="0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.33,0.56,0.89,0.61,0.33,0.25,0.55,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cephalopathy (PML) during natalizumab treatment in multiple </text>
   <text y="499.097" x="310.016,313.517,317.513,320.015,324.011,327.008,331.508,335.009,337.511,341.012,343.262,344.171,347.168,355.169,360.173,363.17,365.42,366.329,370.829,374.825,377.327,379.829,383.825,388.325,390.827,394.328,396.578,398.828,399.737,402.734,405.236,407.486,408.395,412.895,416.891,420.392,422.642,423.551,428.051,432.047,436.043,440.543,442.793,443.702,447.203,451.703,456.203,460.703,464.699,468.2,470.702,474.698,479.198,481.448,482.357,484.859,489.359,493.355,495.857,498.107,499.016,503.516,507.512,510.014,512.516,516.512,521.012,523.514,527.015,529.265,530.174,536.672,541.172,545.672" svgx:width="0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.89,0.56,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.33,0.28,0.25,0.55,0.5,0.44,0.39,0.25,0.55,0.5,0.44,0.44,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sclerosis (MS) patients. It has been suggested that patients who </text>
   <text y="510.095" x="310.016,314.012,317.009,321.005,323.093,325.595,330.095,332.597,335.099,337.601,341.597,344.099,346.601,351.101,353.189,355.691,359.687,363.188,365.69,369.686,374.186,376.274,379.775,383.771,386.768,391.268,395.768,399.764,404.264,408.26,410.762,413.264,417.764,421.76,423.848,427.844,431.84,436.34,438.428,442.424,446.924,451.424,455.924,459.92,462.917,465.419,467.507,470.009,474.509,476.597,480.098,484.094,487.091,491.591,496.091,500.591,504.092,506.594,509.096,511.598,516.098,520.094,522.182,526.682,531.182,534.179,536.681,541.181,545.681" svgx:width="0.44,0.33,0.44,0.25,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.25,0.28,0.44,0.39,0.28,0.44,0.5,0.25,0.39,0.44,0.33,0.5,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.44,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.33,0.28,0.25,0.28,0.5,0.25,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">are initially tested seronegative can convert to seropositive during </text>
   <text y="521.093" x="310.016,314.516,318.512,321.014,325.01,327.512,330.014,334.01,338.51,345.512,349.508,354.008,356.258,358.76,361.757,365.753,369.749,372.251,379.253,383.249,387.749,390.251" svgx:width="0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">natalizumab treatment.</text>
   <text y="532.091" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="532.091" x="355.799,361.298,365.798,369.794,372.089,376.085,378.587,385.589,387.884,392.384,395.381,397.676,400.178,404.678,408.674,410.969,415.469,418.466,422.462,425.963,429.959,434.459,436.961,439.256,442.757,445.259,449.759,454.259,458.759,461.054,467.552,471.548,475.049,477.344,479.846,484.346,486.641,490.637,495.137,499.133,501.635,506.135,510.131,512.633,516.629,518.915,521.417,525.917,529.913,532.208,535.205,539.201,541.703,545.699" svgx:width="0.61,0.5,0.44,0.25,0.44,0.28,0.78,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The aim of the present study was to evaluate the rate </text>
   <text y="543.089" x="310.016,314.516,317.513,319.763,323.759,328.259,332.759,337.259,341.255,344.252,347.753,350.255,354.755,359.255,361.505,364.007,368.507,370.757,378.758,383.762,386.012,390.512,394.508,397.01,399.512,403.508,408.008,410.51,414.011,416.261,420.761,425.261,428.258,430.76,435.26,439.76,442.01,446.51,450.506,453.008,457.004,459.506,462.008,466.004,470.504,477.506,481.502,486.002,488.252,490.754,493.751,497.747,501.743,504.245,511.247,515.243,519.743,522.245" svgx:width="0.5,0.33,0.25,0.44,0.5,0.5,0.5,0.44,0.33,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of conversion in MS patients during natalizumab treatment.</text>
   <text y="554.087" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="554.087" x="349.112,355.115,359.111,361.613,368.111,372.107,376.103,380.603,383.204,391.205,395.201,398.198,402.194,406.694,409.295,413.795,418.295,422.795,427.295,429.896,433.892,438.392,442.892,445.493,448.994,453.494,455.996,460.496,463.097,467.597,472.097,476.597,481.097,483.347,485.948,490.448,494.948,499.448,502.049,510.05,515.054,517.655,522.155,526.151,528.653,531.155,535.151,539.651,542.153,545.654" svgx:width="0.67,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.89,0.44,0.33,0.44,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.28,0.5,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Between March 2007 and July 2013, 168 MS patients </text>
   <text y="565.085" x="310.016,313.517,316.019,320.015,323.012,325.514,329.51,334.01,335.909,340.409,344.405,346.907,350.903,353.405,355.907,359.903,364.403,371.405,375.401,379.901,381.8,384.302,388.802,390.701,393.203,397.703,401.699,403.598,411.599,416.603,418.502,424.505,428.501,433.001,435.503,439.499,442.496,444.395,448.895,451.892,453.791,456.293,460.793,464.789,466.526,473.024,479.522,481.421,489.422,493.418,497.918,500.42,504.416,508.412,510.914,512.813,518.816,522.812,527.312,529.814,533.81,536.807,538.697,541.199,545.699" svgx:width="0.39,0.28,0.44,0.33,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.89,0.56,0.25,0.67,0.44,0.5,0.28,0.44,0.33,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.72,0.72,0.25,0.89,0.44,0.5,0.28,0.44,0.44,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.33,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">started natalizumab in the MS Center of the VU Medical Center in </text>
   <text y="576.083" x="310.016,316.514,323.516,327.017,329.519,333.515,336.512,341.012,345.008,352.01,354.26,356.51,358.544,363.548,366.545,371.045,378.047,380.297,382.331,386.327,388.829,391.331,393.581,395.615,400.115,404.111,406.613,409.115,413.111,417.611,420.113,423.614,425.864,428.114,430.148,434.648,437.645,441.641,444.638,449.138,453.134,455.636,459.632,462.134,464.636,468.632,473.132,480.134,484.13,488.63,490.88,492.914,496.91,501.41,505.91,508.16,510.194,513.191,517.691,520.193,522.695,527.195,533.693,536.69,541.19,545.69" svgx:width="0.72,0.78,0.39,0.28,0.44,0.33,0.5,0.44,0.78,0.25,0.25,0.55,0.56,0.33,0.5,0.78,0.25,0.55,0.44,0.28,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.5,0.33,0.44,0.33,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Amsterdam. From all patients, pre-natalizumab and follow-up </text>
   <text y="587.081" x="310.016,313.517,317.513,320.51,325.01,332.012,334.001,337.502,341.498,348.5,353.0,355.502,359.498,362.999,364.988,371.486,375.482,378.479,382.475,384.464,388.964,393.464,395.966,399.962,402.464,406.964,410.96,415.46,417.449,421.949,424.946,431.948,436.448,440.948,443.45,447.95,450.452,454.952,456.941,460.937,465.437,469.937,471.926,475.427,477.929,482.429,485.426,489.422,493.922,495.911,499.907,502.409,504.398,507.395,509.384,513.884,518.384,521.174,527.177,529.166,533.666,538.166,540.668,543.17,545.672" svgx:width="0.39,0.44,0.33,0.5,0.78,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.28,0.5,0.33,0.44,0.5,0.25,0.44,0.28,0.25,0.33,0.25,0.5,0.5,0.31,0.67,0.25,0.5,0.5,0.28,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">serum samples were obtained 3-monthly and stored at - 80ÂºC until </text>
   <text y="598.079" x="310.016,314.012,318.512,322.508,325.01,329.51,333.011,335.513,339.014,341.264,343.514,347.186,353.189,355.439,359.606,363.107,367.103,371.099,375.599,380.099,384.599,387.596,392.096,396.092,400.592,404.588,407.585,411.581,414.083,416.585,421.085,425.585,427.835,432.002,435.503,441.506,447.842,450.092,454.259,458.255,462.755,465.257,467.759,472.259,476.759,481.259,485.759,488.009,492.176,496.172,500.672,504.668,509.168,516.17,520.166,523.163,525.665,528.167,532.667,537.167,541.163,545.663" svgx:width="0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.72,0.25,0.55,0.39,0.44,0.44,0.5,0.5,0.5,0.33,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.39,0.67,0.72,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.44,0.5,0.78,0.44,0.33,0.28,0.28,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">analysis. A second-generation JCV antibody enzyme-linked </text>
   <text y="609.077" x="310.016,312.518,319.52,326.522,331.022,335.522,340.022,343.523,348.023,351.02,355.52,359.516,364.016,366.518,368.768,370.379,374.375,377.876,381.377,385.373,389.873,392.123,393.734,396.731,402.23,407.729,410.726,415.73,422.228,425.225,427.475,429.086,432.083,437.087,442.586,448.589,454.088,459.587,462.584,467.588,473.753,476.003,477.614,481.115,487.118,493.616,496.613,498.863,500.474,506.972,510.968,514.469,516.719,518.33,522.83,526.331,530.327,534.827,537.077,538.688,541.19,545.69" svgx:width="0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.5,0.33,0.5,0.44,0.5,0.28,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.33,0.61,0.61,0.33,0.56,0.72,0.33,0.25,0.55,0.33,0.56,0.61,0.67,0.72,0.61,0.33,0.56,0.72,0.25,0.55,0.39,0.67,0.72,0.33,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">immunosorbent assay (ELISA) (STRATIFY JCV) was used to </text>
   <text y="620.075" x="310.016,314.516,318.512,321.014,325.01,328.007,335.009,337.511,342.011,346.007,348.257,352.892,355.394,359.894,363.89,366.14,370.775,374.276,380.279,386.615,388.865,393.5,397.496,401.996,404.498,407.0,411.5,416.0,420.5,425.0,427.25,431.885,434.387,436.889,439.391,443.387,446.384,449.885,452.135,456.77,459.272,463.772,466.022,470.657,474.158,478.154,481.151,485.651,492.653,494.903,499.538,504.038,508.538,510.788,515.423,521.921,526.421,528.923,531.425,535.421,539.921,543.422,545.672" svgx:width="0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.67,0.72,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.28,0.28,0.44,0.33,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.44,0.33,0.5,0.78,0.25,0.55,0.5,0.5,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.5,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">determine the JCV antibody titers in serum by Unilabs, </text>
   <text y="631.073" x="310.016,313.013,319.016,323.516,328.016,332.012,336.512,341.012,345.008,349.508,353.504,358.004,360.254,362.504,369.002,372.998,377.498,384.5,388.496,391.493,395.993,398.99,401.24,403.49,410.492,414.488,417.989,422.489,426.485,430.985,433.235,436.232,440.732,443.729,445.979,449.975,452.477,454.979,459.479,461.981,465.977,469.973,472.475,474.725,479.225,483.221,485.723,489.719" svgx:width="0.33,0.67,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.25,0.72,0.44,0.5,0.78,0.44,0.33,0.5,0.33,0.25,0.25,0.78,0.44,0.39,0.5,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(Copenhagen, Denmark), masked for clinical data.</text>
   <text y="642.071" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="642.071" x="344.909,351.407,353.909,356.159,357.806,362.306,366.302,369.803,373.799,376.301,378.803,383.303,387.299,389.549,391.799,393.446,397.946,402.446,404.696,406.343,410.843,414.839,417.341,419.843,423.839,428.339,430.841,434.342,436.592,438.239,444.737,448.733,451.73,455.726,457.976,459.623,462.125,466.121,469.622,472.124,476.12,480.62,482.87,484.517,488.018,492.014,495.011,499.511,504.011,508.007,512.507,516.503,519.005,521.507,526.007,530.003,532.253,534.503,536.15,542.648,545.645" svgx:width="0.72,0.28,0.25,0.55,0.5,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.44,0.39,0.28,0.44,0.5,0.25,0.55,0.39,0.44,0.33,0.5,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.55,0.72,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">At baseline, 64 patients were tested seronegative. Of </text>
   <text y="653.069" x="310.016,312.518,317.018,321.014,324.515,328.511,330.716,335.216,339.212,341.714,344.216,348.212,352.712,355.214,358.715,360.965,363.17,367.67,372.17,374.375,377.372,381.872,386.372,388.622,393.122,400.619,403.616,405.821,409.817,414.317,418.817,423.317,427.313,430.31,432.812,436.808,441.308,443.513,446.015,450.515,452.72,456.221,460.217,463.214,467.714,472.214,476.714,480.215,482.717,485.219,487.721,492.221,496.217,498.467,500.672,506.675,511.175,515.675,520.175,524.171,527.168,530.669,533.171,537.671,542.171,545.672" svgx:width="0.28,0.5,0.44,0.39,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.5,0.5,0.25,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.44,0.5,0.5,0.5,0.44,0.33,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.25,0.67,0.5,0.5,0.5,0.44,0.33,0.39,0.28,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">these patients, 13 (20,3%) converted to seropositive. Conversions </text>
   <text y="664.067" x="310.016,314.516,318.512,322.508,327.008,330.005,333.002,336.998,341.498,343.748,348.248,352.244,354.746,361.244,365.24,369.236,373.736,375.986,380.486,384.986,387.983,392.483,396.983,399.233,406.235,410.735,415.235,417.737,422.237,425.738" svgx:width="0.5,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.5,0.5,0.33,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">occurred between 18-72 months.</text>
   <text y="675.065" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="675.065" x="361.55,367.049,371.549,375.545,377.57,381.071,385.067,388.064,392.564,396.56,401.06,405.56,410.06,414.056,417.053,420.554,423.056,427.556,432.056,434.081,437.078,441.074,443.576,447.572,451.073,453.098,455.6,460.1,462.125,466.625,471.125,474.122,476.147,484.148,489.152,491.177,495.677,499.673,502.175,504.677,508.673,513.173,515.675,519.176,521.201,523.703,526.7,530.696,534.692,537.194,541.19,545.69" svgx:width="0.61,0.5,0.44,0.25,0.39,0.44,0.33,0.5,0.44,0.5,0.5,0.5,0.44,0.33,0.39,0.28,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.5,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The seroconversion rates in our MS patients treated </text>
   <text y="686.063" x="310.016,316.514,319.016,321.518,326.018,328.817,333.317,337.313,339.815,343.811,346.313,348.815,352.811,357.311,364.313,368.309,372.809,375.608,379.604,382.601,386.597,389.396,393.896,396.398,400.898,405.398,409.394,412.391,415.19,417.692,422.192,426.188,430.688,433.487,437.987,442.487,446.987,449.489,451.991,455.492,459.992,463.988,468.488,471.287,475.787,480.287,482.789,485.291,487.793,490.592,495.092,499.592,505.505,507.755,510.392,515.891,520.391,522.893,526.394,529.193,531.695,536.195,540.191,542.693" svgx:width="0.72,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.44,0.33,0.44,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.5,0.25,0.5,0.5,0.5,0.28,0.28,0.39,0.5,0.44,0.5,0.25,0.5,0.5,0.28,0.28,0.28,0.25,0.5,0.5,0.72,0.25,0.25,0.61,0.5,0.28,0.39,0.25,0.28,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with natalizumab are higher than published until now. This inci-</text>
   <text y="697.061" x="310.016,314.516,318.512,323.012,327.008,331.004,333.254,336.17,340.67,343.667,345.917,348.842,352.343,356.339,359.336,363.836,367.832,372.332,376.832,381.332,385.328,388.325,391.826,394.328,398.828,403.328,405.578,408.494,410.996,415.496,417.746,420.671,425.171,429.167,431.669,435.665,438.167,440.669,444.665,449.165,456.167,460.163,464.663,466.913,469.829,472.331,475.328,479.324,483.32,485.822,489.818,494.318,496.568,499.484,507.485,512.489,514.739,517.664,522.164,526.16,528.662,531.164,535.16,539.66,542.162,545.663" svgx:width="0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.44,0.33,0.5,0.44,0.5,0.5,0.5,0.44,0.33,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">dence of seroconversion in natalizumab treated MS patients </text>
   <text y="708.059" x="310.016,314.012,318.512,323.012,327.008,331.004,334.001,337.502,339.752,340.814,343.316,347.816,350.066,351.128,355.628,359.624,361.874,362.936,369.938,374.438,378.434,382.934,385.184,386.246,390.746,393.248,397.748,402.248,406.244,409.241,411.491,412.553,415.055,419.555,423.551,428.051,430.301,431.363,433.865,438.365,440.615,441.677,444.179,448.679,452.675,454.925,455.987,460.487,464.483,468.983,472.979,475.976,479.972,482.474,484.724,485.786,490.286,494.786,499.286,503.786,506.288,510.284,512.786,515.288,519.788,524.288,526.538,528.788,529.688,535.187,539.687,542.189,545.69" svgx:width="0.44,0.5,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.25,0.55,0.78,0.5,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">appears to be much higher than in the general population. This </text>
   <text y="719.057" x="310.016,317.018,319.52,324.02,328.52,331.022,333.272,338.051,340.553,345.053,349.553,352.055,356.051,360.047,362.549,366.545,368.795,373.565,377.561,379.811,384.581,389.081,391.583,396.083,400.583,404.579,407.576,409.826,414.596,419.096,423.596,426.098,430.598,434.594,437.591,441.587,446.087,448.589,451.091,453.593,456.095,460.595,462.845,467.615,472.115,476.615,480.611,482.861,487.64,490.142,494.642,496.892,501.662,506.162,510.158,512.66,516.656,519.158,521.66,525.656,530.156,537.158,541.154,545.654" svgx:width="0.78,0.28,0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.25,0.55,0.44,0.25,0.55,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.55,0.5,0.5,0.28,0.5,0.44,0.33,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">might indicate a higher vulnerability due to natalizumab </text>
   <text y="730.055" x="310.016,312.518,315.515,319.511,323.507,326.009,333.011,337.007,341.507,344.009" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment.</text>
  </g>
 </g>
</svg>
